Tussilagone Inhibits Osteoclastogenesis and Periprosthetic Osteolysis by Suppressing the NF-κB and P38 MAPK Signaling Pathways
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2020.00385
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 3, 2020
Authors
Publisher
Frontiers Media SA